319 related articles for article (PubMed ID: 11563881)
1. Infliximab downregulates interferon-gamma production in activated gut T-lymphocytes from patients with Crohn's disease.
Agnholt J; Kaltoft K
Cytokine; 2001 Aug; 15(4):212-22. PubMed ID: 11563881
[TBL] [Abstract][Full Text] [Related]
2. In vitro analysis of interferon gamma (IFN-gamma) and interleukin-12 (IL-12) production and their effects in ileal Crohn's disease.
Colpaert S; Vastraelen K; Liu Z; Maerten P; Shen C; Penninckx F; Geboes K; Rutgeerts P; Ceuppens JL
Eur Cytokine Netw; 2002; 13(4):431-7. PubMed ID: 12517728
[TBL] [Abstract][Full Text] [Related]
3. Down-regulation of the nonspecific and antigen-specific T cell cytokine response in ankylosing spondylitis during treatment with infliximab.
Zou J; Rudwaleit M; Brandt J; Thiel A; Braun J; Sieper J
Arthritis Rheum; 2003 Mar; 48(3):780-90. PubMed ID: 12632433
[TBL] [Abstract][Full Text] [Related]
4. A soluble factor produced by lamina propria mononuclear cells is required for TNF-alpha enhancement of IFN-gamma production by T cells.
Prehn JL; Landers CJ; Targan SR
J Immunol; 1999 Oct; 163(8):4277-83. PubMed ID: 10510366
[TBL] [Abstract][Full Text] [Related]
5. 1,25-dihydroxyvitamin D3 and dexamethasone increase interleukin-10 production in CD4+ T cells from patients with Crohn's disease.
Bartels LE; Jørgensen SP; Agnholt J; Kelsen J; Hvas CL; Dahlerup JF
Int Immunopharmacol; 2007 Dec; 7(13):1755-64. PubMed ID: 17996686
[TBL] [Abstract][Full Text] [Related]
6. A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease.
Plevy SE; Landers CJ; Prehn J; Carramanzana NM; Deem RL; Shealy D; Targan SR
J Immunol; 1997 Dec; 159(12):6276-82. PubMed ID: 9550432
[TBL] [Abstract][Full Text] [Related]
7. Functional modulation of Crohn's disease myofibroblasts by anti-tumor necrosis factor antibodies.
Di Sabatino A; Pender SL; Jackson CL; Prothero JD; Gordon JN; Picariello L; Rovedatti L; Docena G; Monteleone G; Rampton DS; Tonelli F; Corazza GR; MacDonald TT
Gastroenterology; 2007 Jul; 133(1):137-49. PubMed ID: 17631138
[TBL] [Abstract][Full Text] [Related]
8. The effect of etanercept and infliximab on the production of tumour necrosis factor alpha, interferon-gamma and GM-CSF in in vivo activated intestinal T lymphocyte cultures.
Agnholt J; Dahlerup JF; Kaltoft K
Cytokine; 2003 Aug; 23(3):76-85. PubMed ID: 12906870
[TBL] [Abstract][Full Text] [Related]
9. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists.
Hamdi H; Mariette X; Godot V; Weldingh K; Hamid AM; Prejean MV; Baron G; Lemann M; Puechal X; Breban M; Berenbaum F; Delchier JC; Flipo RM; Dautzenberg B; Salmon D; Humbert M; Emilie D;
Arthritis Res Ther; 2006; 8(4):R114. PubMed ID: 16859506
[TBL] [Abstract][Full Text] [Related]
11. Infliximab therapy decreases the levels of TNF-alpha and IFN-gamma mRNA in colonic mucosa of ulcerative colitis.
Olsen T; Cui G; Goll R; Husebekk A; Florholmen J
Scand J Gastroenterol; 2009; 44(6):727-35. PubMed ID: 19294580
[TBL] [Abstract][Full Text] [Related]
12. Decreased lamina propria effector cell responsiveness to interleukin-10 in ileal Crohn's disease.
Colpaert S; Vanstraelen K; Liu Z; Penninckx F; Geboes K; Rutgeerts P; Ceuppens J
Clin Immunol; 2002 Jan; 102(1):68-76. PubMed ID: 11781069
[TBL] [Abstract][Full Text] [Related]
13. Quantitative gene expression of cytokines in peripheral blood leukocytes stimulated in vitro: modulation by the anti-tumor nerosis factor-alpha antibody infliximab and comparison with the mucosal cytokine expression in patients with ulcerative colitis.
Moriconi F; Raddatz D; Ho NA; Yeruva S; Dudas J; Ramadori G
Transl Res; 2007 Oct; 150(4):223-32. PubMed ID: 17900510
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
[TBL] [Abstract][Full Text] [Related]
15. Interferon (IFN)-gamma is a main mediator of keratinocyte (HaCaT) apoptosis and contributes to autocrine IFN-gamma and tumour necrosis factor-alpha production.
Konur A; Schulz U; Eissner G; Andreesen R; Holler E
Br J Dermatol; 2005 Jun; 152(6):1134-42. PubMed ID: 15948973
[TBL] [Abstract][Full Text] [Related]
16. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma.
Dajotoy T; Andersson P; Bjartell A; Löfdahl CG; Tapper H; Egesten A
J Leukoc Biol; 2004 Sep; 76(3):685-91. PubMed ID: 15197236
[TBL] [Abstract][Full Text] [Related]
17. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.
Parronchi P; Romagnani P; Annunziato F; Sampognaro S; Becchio A; Giannarini L; Maggi E; Pupilli C; Tonelli F; Romagnani S
Am J Pathol; 1997 Mar; 150(3):823-32. PubMed ID: 9060820
[TBL] [Abstract][Full Text] [Related]
18. rIL-2-activated killer cell generation is influenced by autologous TNF-alpha production.
Lange A; Moniewska A; Fetting R; Ernst M; Flad HD
Nat Immun; 1995; 14(1):2-10. PubMed ID: 7599458
[TBL] [Abstract][Full Text] [Related]
19. In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.
Qin HY; Chaturvedi P; Singh B
Int Immunol; 2004 Dec; 16(12):1723-32. PubMed ID: 15492021
[TBL] [Abstract][Full Text] [Related]
20. Production of intracellular IL-2, TNF-alpha, and IFN-gamma by T cells in B-CLL.
Gallego A; Vargas JA; Castejón R; Citores MJ; Romero Y; Millán I; Durántez A
Cytometry B Clin Cytom; 2003 Nov; 56(1):23-9. PubMed ID: 14582134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
